Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review
Conclusionsa rare case of parathyromatosis due to a combination of two genetic alterations never described. The main issues concern the diagnosis and the radical treatment. Somatostatin analogues may have a useful role in both diagnosis and therapy.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Calcium | Cancer & Oncology | CT Scan | Endocrinology | Genetics | Hyperparathyroidism | Men | Orthopaedics | Osteoporosis | Parathyroidectomy | PET Scan | Sensipar | Vitamin D | Vitamins